Benefits of Cruelty free Drug Testing
Improved Predictive Accuracy
Reduced Development Risk and Cost
Reduced Development Risk and Cost
By capturing human specific metabolism, immune signalling, and organ cross talk, the platform delivers data that is more predictive of clinical outcomes than animal or static in vitro models. This improves confidence in early development decisions and therapeutic index estimation.
Reduced Development Risk and Cost
Reduced Development Risk and Cost
Reduced Development Risk and Cost
Earlier detection of toxicity and failure mechanisms reduces reliance on expensive animal studies and late stage clinical failures. The platform supports faster progression of viable candidates while eliminating compounds with unacceptable risk profiles.
Ethical and Regulatory Alignment
Reduced Development Risk and Cost
Ethical and Regulatory Alignment
The fully animal free design aligns with emerging regulatory guidance on New Approach Methodologies and supports global efforts to reduce animal testing. Defined materials, reproducibility, and mechanistic outputs strengthen the case for regulatory acceptance and long term adoption.